In the US, Cidofovir (cidofovir systemic) is a member of the drug class purine nucleosides and is used to treat CMV Retinitis and Smallpox Vaccine Reaction.
US matches:
- Cidofovir
- Cidofovir Intravenous
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
J05AB12
CAS registry number (Chemical Abstracts Service)
0113852-37-2
Chemical Formula
C8-H14-N3-O6-P
Molecular Weight
279
Therapeutic Category
Antiviral agent
Chemical Name
Phosphonic acid, [[2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-, (S)-
Foreign Names
- Cidofovirum (Latin)
- Cidofovir (German)
- Cidofovir (French)
- Cidofovir (Spanish)
Generic Names
- Cidofovir (OS: DCF)
- Cidofovir (OS: USAN, BAN)
- GS 0504 (IS: Gilead)
- GS 504 (IS: Gilead)
- HPMPC (IS: Gilead)
Brand Names
- Vistide
Gilead, Austria; Gilead, Switzerland; Gilead, United Kingdom; Gilead, United States; Gilead Sciences, Sweden; Pfizer, Australia; Pfizer, Belgium; Pfizer, Germany; Pfizer, Spain; Pfizer, France; Pfizer, United Kingdom; Pfizer, Italy; Pfizer, Luxembourg; Pfizer, Portugal; Pfizer, Slovenia; Pharmacia, Czech Republic; Gilead, Netherlands
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and
International Nonproprietary Names.